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Loss-of-function mutations in the cardiac sodium channel α-subunit gene SCN5A result in multiple
inherited arrhythmic syndromes. This case report describes 2 unrelated probands carrying an identical
SCN5A frameshift mutation, V1764fsX1786, who exhibited distinct clinical manifestations: progressive
cardiac conduction defect (PCCD)/Brugada syndrome (patient #1) and idiopathic ventricular ﬁbrillation
(IVF) (patient #2). Using a whole-cell patch clamp technique, cells expressing V1764fsX1786 showed no
observable Na+ current. Therefore, a signiﬁcant phenotypic overlap was found between IVF and PCCD/
Brugada syndrome in the 2 probands with the V1764fsX1786, loss-of-function frameshift mutation of the
cardiac sodium channel gene SCN5A.
& 2013 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.1. Introduction
Loss-of-function mutations in the cardiac sodium (Na+) chan-
nel gene have been implicated in Brugada syndrome, progressive
cardiac conduction defect (PCCD), sick sinus syndrome, and idio-
pathic ventricular ﬁbrillation (IVF) [1]. In the present study, we
describe 2 unrelated index cases of PCCD/Brugada syndrome and
IVF who share an identical 1-base deletion mutation of SCN5A
resulting in a large truncation at the cytoplasmic C-terminal of the
cardiac Na channel (V1764fsX1786). Despite carrying the non-
functional allele, the 2 probands exhibit distinct clinical manifes-
tations and electrophysiological properties. These results support
the notion that the ultimate clinical manifestations of the cardiac
sodium channelopathies are profoundly affected by many unde-
termined factors, including genetic variations of genes other than
SCN5A.t Rhythm Society. Published by Els
+81 6 6872 7486.2. Case report
2.1. Patient 1
A 47-year-old man had recurrent syncope, and his 12-lead
electrocardiogram (ECG) demonstrated a complete right bundle
branch block (QRS width 200 ms), left axis deviation, and the ﬁrst
degree of atrio-ventricular block (Fig. 1A). He subsequently under-
went echocardiography, coronary angiography, and left ventriculo-
graphy, none of which demonstrated any structural heart diseases.
However, continuous ECG monitoring revealed an episode of sinus
arrest for 4 s. A subsequent electrophysiological study (EPS) demon-
strated a prolongation of the atrio-ventricular conduction time (A-H
interval, 100 ms; H-V interval, 75 ms) and extension of sinus node
recovery time (SNRT41500 ms), but neither sustained ventricular
tachycardia (VT) nor ventricular ﬁbrillation (VF) was induced by
programmed electrical stimulation (up to 500/280/220/210 ms from
the right ventricular apex). Based on these results, the patient was
diagnosed with advanced atrio-ventricular block and sick sinus
syndrome, and a pacemaker was implanted. Although he had no
history of obvious VT or VF during the follow-up, he had palpita-
tions during sleep at night, and coved-type Brugada-ECG ﬁndingsevier B.V. All rights reserved.
Fig. 1. A: 12-Lead ECG of patient #1 (proband) at 47 years of age with a complete right bundle branch block (QRS width 200 ms), left axis deviation, and the ﬁrst degree of
atrioventricular block. B: ECG recordings of 12-leads and V1-3 leads on higher inter-cordial spaces (ICS) of patient #1 at 71 years of age with atrial pacing and CRBBB and
coved type ST-segment elevation (0.2 mV at V2 3rd ICS). C: Pedigree and phenotypes of the family members affected by Brugada syndrome and/or conduction disease. +,
V1764fsX1786 carrier; −, non-carrier; S.D., sudden death; and y, years.
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suddenly died during sleep, as had both of his sons at 32 and 22
years old (Fig. 1C). Therefore, when he was 73 years old, a pace-
maker was prophylactically upgraded to an implantable cardiover-
ter deﬁbrillator (ICD). In 2 years after implantation of the ICD, he
had 1 episode of nonsustained VT (CL 380 ms, 4 s), but did not
receive any appropriate ICD-shock therapy.
2.2. Patient 2
An 18-year-old high school student had syncope during mara-
thon training in a physical education class and had cardiopulmon-
ary resuscitation. VF was detected and deﬁbrillated by automated
external deﬁbrillator (Fig. 2A), but his consciousness level did not
fully recover (Japan Coma Scale III-300). He underwent tracheal
intubation and cerebral hypothermia therapy immediately after
hospitalization. Emergency coronary artery angiography was not
performed because he had no coronary risk, lack of ST-T changes
on ECG, and no asynergy or anomalous coronary artery origin on
echocardiography. The patient recovered consciousness without
any cerebral disorder after being rewarmed. He had no family
history of sudden cardiac death. His 12-lead ECG at admission
(Fig. 2B, right panel) showed no signiﬁcant ST-T changes, Brugada-
ECG ﬁndings, J-waves, or prolongation/abbreviation of the QT
interval. No signiﬁcant change in ECG was observed during
exercise or during pharmacologic stress test (pilsicainide or iso-
proterenol). He had no abnormal physical or laboratory ﬁndings,
and computed tomography and magnetic resonance imaging did
not reveal any structural heart diseases such as arrhythmogenic
right ventricular cardiomyopathy and dilated cardiomyopathy.
Although the patient had episodes of spontaneous sinus brady-
cardia (heart rate 37/min) and atrio-ventricular block (Wenck-
ebach type) (Fig. 2C), PCCD was excluded since he exhibited no
obvious atrio-ventricular block or bundle branch block of ECGs,
and his previous ECGs were normal (Fig. 2B, left panel). His signal-
averaged ECG (SAECG) was positive, but T-wave alternans was
negative. EPS showed that the atrio-ventricular conduction time
was prolonged (AH interval, 91 ms; H-V interval, 93 ms) andprogrammed electrical stimuli at the right ventricular apex (up
to 500/220/210 ms) induced VF. Based on these results, the patient
was diagnosed with IVF and an ICD was implanted without any
medications. The patient has not had any ICD-shock therapy
during 2-year of follow up.
2.3. Genetic and functional analysis
Genetic testing was performed on these 2 unrelated probands
and family members, demonstrating the same V1764fsX1786
frameshift mutation of the SCN5A gene (Fig. 3A). The same
mutation was not found in the #1 patient's brother and 2 grand-
sons, or the #2 patient's mother. To functionally characterize the
frameshift mutation, we performed whole-cell patch clamp
recordings as previously described [2]. The mutant or wild-type
Na+ channel was heterologously expressed in tsA-201 cells, and
cells expressing mutant Na+ channel showed no observable
sodium current (Fig. 3B) showing a compatible loss-of-function
mutation.3. Discussion
Mutations in the cardiac Na+ channel α-subunit gene SCN5A cause
several inherited arrhythmogenic syndromes such as long QT syn-
drome type 3 (LQT3), Brugada syndrome, PCCD, and sick sinus node
syndrome. [3–7] Furthermore, loss-of- function mutations in SCN5A
have been reported to be a disease gene for IVF [8]. Even with the
same mutation (e.g. E1784K) of SCN5A, different phenotypes such as
LQT3 and Brugada syndrome were observed [2]. PCCD and Brugada
syndrome present signiﬁcant overlap and can coexist in the same
family and even in the same individual [9–11].
Here we identiﬁed, for the ﬁrst time, 2 unrelated probands who
carried the same SCN5A frameshift mutation, V1764fsX1786, but
exhibited distinct clinical manifestations: PCCD/Brugada syn-
drome and IVF, suggesting overlap Na+ channelopathies.
V1764fsX1786 mutation causes an overlap phenotype between
PCCD and Brugada syndrome [12,13]. As shown in Fig. 1, patient
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Fig. 2. A: Monitoring ECGs of patient #2 with ventricular ﬁbrillation detected by AED. Electrical cardioversions were performed three times by AED before hospitalization.
B: 12-Lead ECGs of patient #2 at 13 years of age and 18 years of age. QRS width age-dependently increased over 6 years. C: Sinus bradycardia and atrioventricular block
(Wenckebach type) were recognized by Holter electrocardiogram. D: Pedigree and phenotypes of the family members affected by idiopathic ventricular ﬁbrillation.
+, V1764fsX1786 carrier; −, non-carrier; and y, years.
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Fig. 3. A: A single nucleotide deletion (G) at position 5290 of the SCN5A locus results in a frameshift mutation: V1764fsX1786. B: Representative whole-cell Na+ current
recordings from tsA-201 cells expressing wild type (WT) or mutant (V1764fsX1786) Na+ channels. Currents were recorded from a holding potential of −120 mV and stepped
from −90 mV to +50 mV for 15 ms in 10 mV increments.
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ECG, syncope attack, and signiﬁcant family history of sudden
cardiac death. It was not possible to ﬁnd out whether his sons
had the frameshift mutation, as they died suddenly during sleep
at night in their 20s or 30s, which might have resulted from VF.
Conversely, patient #2 had an episode of VF without any other
inherited or structural abnormalities, and was thus diagnosed
with IVF. However, the age-dependent increased QRS duration of
his ECG, a prolonged H-V interval, and positive late potential ofthe SAECG were associated with conduction abnormalities. The
timing of events were completely different for patient #1 and his
family (during sleep) and patient #2 (during exercise), but they
are consistent with the phenotype of each (Brugada syndrome
or IVF).
PCCD (Lev or Lenègre disease) manifests as progressive pro-
longation of cardiac conduction (P wave, PR, and QRS intervals),
and right or left bundle branch block, without ST segment
elevation or QT prolongation. These ECG changes are often
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Fig. 4. Schematic representation of SCN5A mutations responsible for PCCD and relevant overlap syndrome.
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ﬁbrosis may affect the conduction system. In young people, the
impaired Na+ channels do not cause severe conduction defect, but
with age, an increase in ﬁbrosis in association with the genetic
defect may impair the propagation of impulses through the
conduction system and reveal the PCCD phenotype [6]. Therefore,
haploinsufﬁciency of SCN5A and aging have been implicated in
PCCD,[14] and a heterozygous mouse model (SCN5A+/−) has
demonstrated age-related conduction slowing and ﬁbrosis quali-
tatively similar to that seen in the PCCD patients [15]. This is
relevant to the Brugada syndrome since conduction slowing is
progressively accentuated in the Brugada probands with SCN5A
mutation compared with those without SCN5A mutation [16].
Conversely, the same mutations in SCN5A (e.g. G1406R) led to
either PCCD or Brugada syndrome in a large French family [9]. As
shown in Fig. 4, more than half of the SCN5A mutations in PCCD
overlap with Brugada syndrome, SSS, and LQT3 [17,1]. PCCD often
predominates in the elderly. Makita et al. recently reported that
the age of onset of PCCD probands showed a wide-range distribu-
tion with 2 peaks in the 20s and 60s [18]; therefore, manifestation
of PCCD due to SCN5A mutations might be an age-dependent
ﬁbrotic change.
The functional analysis of this V1764fsX1786 mutation is
shown in Fig. 3B; no current was observed, indicating severe
loss-of-function. Although we did not investigate the mechanisms
of this complete reduction in Na+ current in this mutation, Herfst
et al [19]. reported a similar frameshift mutation of SCN5A
(5280delG, A1711fsX1786) in a large cardiac conduction defect
family, demonstrating that the A1711fsX1786 mutation results in
the translation into non-function channel proteins that fail to
reach the plasma membrane. Furthermore, Meregalli et al. showed
that Na+ current reduction by frameshift or nonsense mutations is
predicted to be a complete reduction of peak Na+ current asso-
ciated with the severity of conduction slowing such as longer PR
interval and more symptoms [20]. However, disease severity
among mutation carriers is highly variable, and the sodium
channel subunit β4 (SCN4B) may be one of the potential genetic
modiﬁers of conduction and cardiac sodium channel disease [21].
Therefore, phenotype manifestation in the loss-of-function sodium
channel mutations could interact with many factors such as age,
sex, and other modiﬁng genes and proteins. A further genetic
study of patients or family members is important for diagnosis andrisk stratiﬁcation for conduction slowing leading to sudden
cardiac death.4. Conclusion
A signiﬁcant phenotypic overlap was found between IVF and
PCCD/Brugada syndrome in 2 probands with the V1764fsX1786,
loss-of-function frameshift mutation of the cardiac Na+ channel
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